Crouzon syndrome with acanthosis nigricans: Case report and mutational analysis

Cleft Palate-Craniofacial Journal

Volumn 37, Issue 1, 2000, Pages 78-82

  Nagase, Takashi ^a,d   Nagase, Miki ^b   Hirose, Shigehisa ^c   Ohmori, Kitaro ^a  

^a TOKYO METROPOLITAN POLICE HOSPITAL   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^d NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

Author keywords

Acanthosis nigricans; Crouzon syndrome; FGFR 3

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR;

ACANTHOSIS NIGRICANS; ARTICLE; CASE REPORT; CHILD; CROUZON SYNDROME; DYSPNEA; FACIAL NERVE PARALYSIS; GENE MUTATION; HUMAN; MALE; MENTAL DEFICIENCY; PERCEPTION DEAFNESS; PRIORITY JOURNAL; SKIN BIOPSY;

EID: 0033959923     PISSN: 10556656     EISSN: None     Source Type: Journal    
DOI: 10.1597/1545-1569(2000)037<0078:CSWANC>2.3.CO;2     Document Type: Article

References (32)

1. Bellus GA, Gaudenz K, Zackai EH, Clarke LA, Szabo J, Francomano CA, Muenke M. Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes. Nat Genet. 1996;14:174-176.
2. Bellus GA, McIntosh I, Smith EA, Aylsworth AS, Kaitila I, Horton WA, Greenhaw GA, Hecht JT, Francomano CA. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. Nat Genet. 1995;10:357-359.
3. Breitbart AS, Eaton C, McCarthy JG. Crouzon's syndrome associated with acanthosis nigricans: ramifications for the craniofacial surgeon. Ann Plast Surg. 1989;22:310-315.
4. Curth H. The necessity of distinguishing four types of acanthosis nigricans. In: Jadassohn W, Schirren C, eds. XII Congressus Internationalis Dermatologiae Munich. Berlin: Springer-Verlag; 1968:557-558.
5. Gines E, Rodriguez-Pichardo A, Jorquera E, Moreno JC, Camacho F. Crouzon disease with acanthosis nigricans and melanocytic nevi. Pediatr Dermatol. 1996;13:18-21.
6. Gorlin RJ. Fibroblast growth factors, their receptors and receptor disorders. J Craniomaxillofac Surg. 1997;25:69-79.
7. Griffiths W, Leigh I, Marks R. Disorders of keratinization. In: Champion R, Burton J, Ebling F, eds. Textbook of Dermatology. Oxford: Blackwell; 1992:1325-1390.
8. Ishigaki M, Wada C, Toyo-oka Y, Yamabe H, Ohnuki Y, Takada F, Yamazaki Y, Ohtani H. Frequent missense mutations of fibroblast growth factor receptor (FGFR) gene families in craniofacial syndromes in Japanese patients. Jpn J Clin Pathol. 1996;44:439-443. In Japanese.
9. Koizumi H, Tomoyori T, Sato KC, Ohkawara A. An association of acanthosis nigricans and Crouzon syndrome. J Dermatol. 1992;19:122-126.
10. Maize J, Metcalf J. Metabolic diseases of the skin. In: Elder D. Elenitsas R, Jaworsky C, Johnson C Jr, eds. Lever's Histopathology of the Skin. Philadelphia: Lippincott-Raven; 1997:369-402.
11. Martinez-Perez D, Vander Woude DL, Barnes PD, Scott RM, Mulliken JB. Jugular foraminal stenosis in Crouzon syndrome. Pediatr Neurosurg. 1996;25:252-255.
12. Matsumoto K, Urano Y, Kubo Y, Nakanishi H, Arase S. Mutations of the fibroblast growth factor receptor 2 gene in Japanese patients with Apert syndrome. Plast Reconstr Surg. 1998;101:307-311.
13. Meyers GA, Orlow SJ, Munro IR, Przylepa KA, Jabs EW. Fibroblast growth factor receptor 3 (FGFR3) transmembrane mutation in Crouzon syndrome with acanthosis nigricans. Nat Genet. 1995;11:462-464.
14. Moloney DM, Slaney SF, Oldridge M, Wall SA, Sahlin P, Stenman G, Wilkie AOM. Exclusive patternal origin of new mutations in Apert syndrome. Nat Genet. 1996;13:48-53.
15. Muenke M, Gripp KW, McDonald-McGinn DM, Gaudenz K, Whitaker LA, Bartlett SP, Markowitz RI, Robin NH, Nwokoro N, Mulvihill JJ, Losken HW, Mulliken JB, Guttmacher AE, Wilroy RS, Clarke LA, Hollway G, Ades LC, Haan EA, Mulley JC, Cohen MM Jr, Bellus GA, Francomano CA, Moloney DM, Wall SA, Wilkie AO. A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. Am J Hum Genet. 1997;60:555-564.
16. Muenke M, Schell U, Hehr A, Robin NH, Losken HW, Schinzel A, Pulleyn LJ, Rutland P, Reardon W, Malcolm S, Winter RM. A common mutation in the fibroblast growth factor receptor I gene in Pfeiffer syndrome. Nat Genet. 1994;8:269-274.
17. Nagase T, Nagase M, Hirose S, Ohmori K. Japanese sisters with Pfeiffer syndrome and achondroplasia: a mutation analysis. J Craniofac Surg. 1998a;9:477-480.
18. Nagase T, Nagase M, Hirose S, Ohmori K. Mutations in fibroblast growth factor receptor 2 gene and craniosynostosis syndromes in Japanese children. J Craniofac Surg. 1998b;9:162-170.
19. Orlow SJ. Cutaneous findings in craniofacial malformation syndromes. Arch Dermatol. 1992;128:1379-1386.
20. Orr-Urtreger A, Givol D, Yayon A, Yarden Y, Lonai P. Developmental expression of two murine fibroblast growth factor receptors, flg and bek. Development. 1991;113:1419-1434.
21. Peters K, Ornitz D, Werner S, Williams L. Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis. Dev Biol. 1993;155:423-430.
22. Reardon W, Winter RM, Rutland P, Pulleyn LJ, Jones BM, Malcolm S. Mutations in the fibroblast growth factor receptor 2 gene cause Crouzon syndrome. Nat Genet. 1994;8:98-103.
23. Reddy BS, Garg BR, Padiyar NV, Krishnaram AS. An unusual association of acanthosis nigricans and Crouzon's disease - a case report. J Dermatol. 1985;12:85-90.
24. Risch N, Reich EW, Wishnick MM, McCarthy JG. Spontaneous mutation and parental age in humans. Am J Hum Genet. 1987;41:218-248.
25. Rousseau F, Bonaventure J, Legeal-Mallet L, Pelet A, Rozet J-M, Maroteaux P, Merrer ML, Munnich A. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature. 1994;371:252-254.
26. Shiang R, Thompson LM, Zhu Y-Z, Church DM, Fielder TJ, Bocian M, Winokur ST, Wasmuth JJ. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell. 1994;78:335-342.
27. Superti-Furga A, Eich G, Bucher HU, Wisser J, Giedion A, Gitzelmann R, Steinmann B. A glycine 375-to-cysteine substitution in the transmembrane domain of the fibroblast growth factor receptor-3 in a newborn with achondroplasia. Eur J Pediatr. 1995;154:215-219.
28. Superti-Furga A, Locher M, Steinlin M, Eich G, Huisman T, Steinmann B, Sailer H, Boltshauser E. Crouzon syndrome with acanthosis nigricans, spinal stenosis and desmo-osteoblastomas: pleiotropic effects of the FGFR-3 ALA-391-GLU mutation. J Craniomaxillofac Surg. 1996;24(suppl 1):112.
29. Suslak L, Glista B, Gertzman GB, Lieberman L, Schwartz RA, Desposito F. Crouzon syndrome with periapical cemental dysplasia and acanthosis nigricans: the pleiotropic effect of a single gene? Birth Defects 1985;21:127-134.
30. Tavormina PL, Shiang R, Thompson LM, Zhu Y-Z, Wilkin DJ, Lachman RS, Wilcox WR, Rimoin DL, Cohn DH, Wasmuth JJ. Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nat Genet. 1995;9:321-328.
31. Wada C, Ishigaki M, Toyo-oka Y, Yamabe H, Ohnuki Y, Takada F. Yamazaki Y, Ohtani H. Nucleotide sequences at intron 6 and exon 7 junction of fibroblast growth factor receptor 2 and rapid mutational analysis in Apert syndrome. Jpn J Clin Pathol. 1996;44:435-438. In Japanese.
32. Wilkes D, Rutland P, Pulleyn LJ, Reardon W, Moss C, Ellis JP, Winter RM, Malcolm S. A recurrent mutation, Ala391Glu, in the transmembrane region of FGFR3 causes Crouzon syndrome and acanthosis nigricans. J Med Genet. 1996;33:744-748.